Anju has been acquired by ABRY Partners

Anju Software, a clinical, medical affairs and commercial software and data platform for the life sciences industry, has received a majority investment from ABRY Partners.

• The transaction provides growth and acquisition capital for continued product enhancement and global expansion
• ABRY Partners has deep industry expertise across multiple technology subsectors, including healthcare IT, SaaS and information services

Anju Software

Anju Software is a leading provider of comprehensive software solutions to the life sciences industry. Anju provides an integrated platform spanning clinical, medical affairs and commercial operations.  Anju solutions are used by large and small pharmaceutical companies, clinical research organizations (CRO), full service agencies and medical device companies.  Data flow between functional areas, seamless communication with third party systems and AI-based data mining solutions to provide customers critical information throughout their ecosystem.

About ABRY Partners

Since its founding in 1989, ABRY has focused on media, communications, business and information services to become one of the most experienced private equity firms investing in North America and Europe. ABRY’s funds are deployed by our close-knit and diverse team of professionals, most of whom have built their careers at the firm.